Stockscreener 앱 받기
1.45
3.57%
0.05
시간 외 거래:
1.39
-0.06
-4.14%
전일 마감가:
$1.40
열려 있는:
$1.38
하루 거래량:
1.98M
Relative Volume:
0.60
시가총액:
$1.50M
수익:
-
순이익/손실:
$-6.90M
주가수익비율:
-0.1035
EPS:
-14.0152
순현금흐름:
$-6.65M
1주 성능:
+27.19%
1개월 성능:
-67.71%
6개월 성능:
-45.24%
1년 성능:
-78.03%
1일 변동 폭
$1.33
$1.47
1주일 범위
$1.095
$2.09
52주 변동 폭
$1.03
$16.68
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
명칭
Bluejay Diagnostics Inc
전화
(978) 631-0152
주소
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.45 | 1.50M | 0 | -6.90M | -6.65M | -14.02 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc 주식(BJDX)의 최신 뉴스
Form 4 Bluejay Diagnostics Inc For: 10 July By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) shows Bank of America entities as 10% owners - Stock Titan
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) sees 8 shares reported by Bank of America - Stock Titan
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Cash Runway - StocksToTrade
BJDX Stock Slides As Traders Gauge Cash Runway And Volatility - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Support Levels - StocksToTrade
BJDX Stock Slides As Traders Study Volatile Chart - timothysykes.com
BJDX Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade
Bluejay Diagnostics stock rally meets a June warrant wall after pre-market churn - TechStock²
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BJDX Stock Slides As Traders Watch Support Levels - timothysykes.com
Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics - TipRanks
Market Movers | Winners: TRNR, DCOY, ATLN | Losers: BJDX, EVMN, CELZ - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
[EFFECT] Bluejay Diagnostics, Inc. SEC Filing - Stock Titan
Bluejay Diagnostics (BJDX) Falls 11.5% as Selling Pressure Intensifies; Support at $2.78 in FocusSentiment Divergence - dars.gov.et
Bluejay Diagnostics (BJDX) registers 11.2M resale shares; warrants tied to cash proceeds - Stock Titan
Price to sales forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Enterprise value to revenue forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Enterprise value to EBIT forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Enterprise value to EBITDA forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
BJDX Q4 2023 Earnings: EPS Misses Estimates by a Wide Margin Amid Operational ChallengesCapex Guidance - dars.gov.et
BJDX Q4 2023 Earnings: Significant EPS Miss as Diagnostics Firm Reports No Revenue; Shares RallyDownward Estimate Revision - dars.gov.et
Bluejay Diagnostics Inc (BJDX) Institutional Confidence - TradingKey
Bluejay Diagnostics (BJDX) Surges 10.7% as Rally Tests Key ResistanceGEX Level - dars.gov.et
Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BJDX SEC FilingsBluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bluejay Diagnostics | SCHEDULE 13D: Others - Moomoo
Bluejay Diagnostics Inc (BJDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bluejay Diagnostics (NASDAQ: BJDX) registers 11.2M resale shares from warrant holders - Stock Titan
Bluejay Diagnostics Inc (BJDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bluejay Diagnostics Inc (BJDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BJDX Q4 2023 Earnings: Wider-than-Expected Loss Deepens as Pre-Revenue Diagnostics Firm Navigates Cost PressuresEarnings Call Q&A - newsline.com
Bluejay Diagnostics Inc. (BJDX) Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineLong-Term Guidance - newsline.com
BJDX Q4 2023 Earnings: EPS Misses Estimates by Wide Margin as No Revenue ReportedFull Year Guidance - newsline.com
BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue StageMargin Guidance - newsline.com
Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility - TipRanks
Bluejay Diagnostics (NASDAQ: BJDX) expands stock plan and wins reverse split approval - Stock Titan
BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart - ChartMill
Bluejay Diagnostics Announces $23.6 Million Private Placement to Extend Cash Runway Beyond FDA Submission - Minichart
Bluejay Diagnostics Completes Private Placement to Extend Runway - TipRanks
Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants - TradingView
Bluejay Diagnostics (NASDAQ: BJDX) closes $8.5M warrant-backed financing - Stock Titan
Bluejay Diagnostics completes private placement that raised USD 8.5M - Medical Buyer
Bluejay Diagnostics closes $8.5 million private placement By Investing.com - Investing.com Australia
Bluejay Diagnostics (BJDX) Drops 9.43% as Stock Tests Key Support at $4.56Covered Call Trade - dars.gov.et
Bluejay Diagnostics Inc (BJDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
자본화:
|
볼륨(24시간):